Compass Therapeutics (NASDAQ:CMPX) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Compass Therapeutics (NASDAQ:CMPX – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.02), FiscalAI reports. Compass Therapeutics Price Performance Shares of NASDAQ:CMPX traded up $0.16 during mid-day trading on Friday, reaching $2.15. 3,825,555 shares of […]
8 Aug 19:42 · The Markets Daily